CompletedPhase 3

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

United States583 participantsStarted 2008-04

Plain-language summary

RATIONALE: Providing information that is tailored to answer patients' questions about clinical trials may help patients with cancer decide to enroll in a clinical trial. It is not known whether providing personalized information is more effective than basic information in helping patients make decisions about clinical trials. PURPOSE: This randomized phase III trial is studying personalized information to see how well it works compared with basic information in helping patients make decisions about participating in a clinical trial.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Diagnosis of 1 of the following: * Advanced (metastatic) disease * Early stage (i.e., appropriate for adjuvant therapy) disease * Scheduled for first outpatient consultation with a medical oncologist at the Clinical Centers PATIENT CHARACTERISTICS: * Able to read and verbally communicate in English * Patients who choose to complete the intervention at home rather than at the Clinical Center before their visit must have high-speed (i.e., DSL or cable) Internet access PRIOR CONCURRENT THERAPY: * Not specified

What they're measuring

Improvement in preparation for consideration of clinical trials

Timeframe: after pts.complete all survey measures

Trial details

NCT IDNCT00750009

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-12

View on ClinicalTrials.gov More Brain and Central Nervous System Tumors trials